News Focus
News Focus
icon url

jon_k84

12/19/22 6:14 PM

#550845 RE: FeMike #550836

You are I are in agreement with that, I think I'm just a little more optimistic than you.

Momentum is a very real thing, and it would take a lot to stop DCV at this point. We've been hitting one benchmark after the other, and there's nothing I've seen to make me think anything's amiss.

-TLD Released
-Top-tier JAMA article
-Overwhelmingly high % of GBM oncologists are on board with DCV
-Short manipulation lawsuit announced by top tier firm
-MIA approval
...

What is the next bowling pin to fall down? Predicting the exact date and time is a fool's errand, but I don't see the momentum stopping. Would I invest my life savings? No, that would be silly and poor judgement, but I have a sizable position, and I feel very confident about it.
Bullish
Bullish
icon url

OncoJock

12/19/22 10:41 PM

#550961 RE: FeMike #550836

Agree, but we cannot buy shares in Advent because it is privately held by LP and her husband Robert Hemphill, if memory serves.
icon url

biosectinvestor

12/19/22 10:55 PM

#550972 RE: FeMike #550836

The certification is critical for the application. You can’t get your application in or approval done without it. They have no doubt run through all of the critical SOP’s not just for general dendritic cell and cell based processing, but the specific needs that are required by this contract manufacturer to perform its primary contract duties which involve the storage and manufacture of DCVax and similar biologicals. They are not a manufacturer of aspirin.